<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>阿斯利康、辉瑞、诺华…透视 MNC 2023 上半年公开的肿瘤领域专利 - 文字轨迹</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/2023-08/%E9%98%BF%E6%96%AF%E5%88%A9%E5%BA%B7_%E8%BE%89%E7%91%9E_%E8%AF%BA%E5%8D%8E_%E9%80%8F%E8%A7%86_mnc_2023_%E4%B8%8A%E5%8D%8A%E5%B9%B4%E5%85%AC%E5%BC%80%E7%9A%84%E8%82%BF%E7%98%A4%E9%A2%86%E5%9F%9F%E4%B8%93%E5%88%A9/"><meta property="og:site_name" content="文字轨迹"><meta property="og:title" content="阿斯利康、辉瑞、诺华…透视 MNC 2023 上半年公开的肿瘤领域专利"><meta property="og:description" content="阿斯利康、辉瑞、诺华…透视 MNC 2023 上半年公开的肿瘤领域专利 by Insight数据库 随着各大制药陆续披露各自 2023 上半年的业绩报告，肿瘤业务在其营收中的贡献也逐一浮出水面。"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2023-08-04T23:01:33+00:00"><meta property="article:modified_time" content="2023-08-04T23:01:33+00:00"><meta property="article:tag" content="Fetched"><meta property="article:tag" content="Insight数据库"><meta itemprop=name content="阿斯利康、辉瑞、诺华…透视 MNC 2023 上半年公开的肿瘤领域专利"><meta itemprop=description content="阿斯利康、辉瑞、诺华…透视 MNC 2023 上半年公开的肿瘤领域专利 by Insight数据库 随着各大制药陆续披露各自 2023 上半年的业绩报告，肿瘤业务在其营收中的贡献也逐一浮出水面。"><meta itemprop=datePublished content="2023-08-04T23:01:33+00:00"><meta itemprop=dateModified content="2023-08-04T23:01:33+00:00"><meta itemprop=wordCount content="224"><meta itemprop=keywords content="Fetched,Insight数据库"><meta name=twitter:card content="summary"><meta name=twitter:title content="阿斯利康、辉瑞、诺华…透视 MNC 2023 上半年公开的肿瘤领域专利"><meta name=twitter:description content="阿斯利康、辉瑞、诺华…透视 MNC 2023 上半年公开的肿瘤领域专利 by Insight数据库 随着各大制药陆续披露各自 2023 上半年的业绩报告，肿瘤业务在其营收中的贡献也逐一浮出水面。"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=文字轨迹 rel=home><div class="logo__item logo__text"><div class=logo__title>文字轨迹</div><div class=logo__tagline>故事流淌过的地方</div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>文章</span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>标签</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>关于</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>阿斯利康、辉瑞、诺华…透视 MNC 2023 上半年公开的肿瘤领域专利</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2023-08-04T23:01:33Z>2023-08-04</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/duty/ rel=category>Duty</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#阿斯利康辉瑞诺华透视-mnc-2023-上半年公开的肿瘤领域专利-by-insight数据库>阿斯利康、辉瑞、诺华…透视 MNC 2023 上半年公开的肿瘤领域专利 by Insight数据库</a></li></ul></nav></div></div><div class="content post__content clearfix"><h2 id=阿斯利康辉瑞诺华透视-mnc-2023-上半年公开的肿瘤领域专利-by-insight数据库>阿斯利康、辉瑞、诺华…透视 MNC 2023 上半年公开的肿瘤领域专利 by Insight数据库</h2><div><section data-mpa-powered-by=yiban.io><img data-backh=156 data-backw=562 data-ratio=0.2777777777777778 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYF5Asn2uWS6ibKUibMjNE0VdQA1EQyZgTiahTWw3jjtRoiaBXefv90xXX0TfIyU2dNXmKDh7ubyX8n1Q/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type=png data-w=900 height=250px width=900 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYF5Asn2uWS6ibKUibMjNE0VdQA1EQyZgTiahTWw3jjtRoiaBXefv90xXX0TfIyU2dNXmKDh7ubyX8n1Q/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></section><section><br></section><section><span>随着各大制药陆续披露各自 2023 上半年的业绩报告，肿瘤业务在其营收中的贡献也逐一浮出水面。</span></section><section><span><br></span></section><section><span>初步调研发现，<strong>辉瑞</strong>、<strong>阿斯利康</strong>、<strong>艾伯维</strong>、<strong>诺华</strong>与<strong>葛兰素史克（GSK）</strong>等公司上半年公开的肿瘤相关（分类号中含有 A61P35）PCT 专利在数量上均少于前期调研的罗氏公司</span><span>（详见往期文章>>></span><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA4MzkzMDYyNw==&amp;mid=2649893931&amp;idx=1&amp;sn=d688c270e9396d8438047daffdcfb20b&amp;chksm=87e87747b09ffe5177fcd148b9902e3eec9e667721b54b35893dbf4a060b4564e35686cb9e3a&amp;scene=21#wechat_redirect" textvalue="透视罗氏制药 2023 上半年公开的肿瘤领域专利" linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2><span>透视罗氏制药 2023 上半年公开的肿瘤领域专利</span></a><span>）</span><span>，但<strong>在发明主题上却各有千秋。</strong></span></section><section><span><br></span></section><section><span>由于 PCT 途径是大部分申请人进行国际申请的首选途径，而且大部分 PCT 申请的公开日均早于其同族专利申请，<strong>故本文以</strong> <strong>2023 上半年公开的上述 MNC 申请的肿瘤相关 PCT 专利为线索，简要地分析各 MNC 最新的研发动态与方向。</strong></span></section><section><br></section><section><br></section><p><img data-backh=52 data-backw=562 data-galleryid data-ratio=0.09166666666666666 data-s=300,640 data-src="https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZZELxGdzcvb5smTN1Jpa5oSNVoeeMhPsWC6JvHGAhMNaWpTzd5Xup3rRSuibpcdEn0bBBx30uuEsKw/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type=png data-w=1080 src="https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZZELxGdzcvb5smTN1Jpa5oSNVoeeMhPsWC6JvHGAhMNaWpTzd5Xup3rRSuibpcdEn0bBBx30uuEsKw/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></p><section><span><strong>小分子化合物</strong></span></section><section><span><br></span></section><section><span><span><strong><span> </span></strong></span><span><strong><span>  基础化合物专利</span></strong></span></span></section><section><br></section><section><span><em><span>写在前面：</span></em></span></section><section><br></section><section><span>本文所列的示例化合物结构中对于各专利大部分示例化合物所共有的部分以红色标识，共有部分中仍然可变的原子则以蓝色标识。</span></section><section><span><br></span></section><section><span><strong><span>1、选择性雄激素受体调控剂（SARMs）</span></strong></span></section><section><br></section><section><span>辉瑞申请的 WO2023275715 公开了作为 SARM 的化合物 1.1.1 的代谢产物，包括硫杂六氢嘧啶环的开环产物及 N-葡萄糖醋酸结合物、异喹啉环的氧化产物等，但通篇未披露所述代谢产物活性数据，而是对作为第二活性成分在于含有化合物 1.1.1 代谢产物的组合物中的 MC4R 拮抗剂披露了有关数据。</span></section><section><span><br></span></section><section><span>化合物 1.1.1</span></section><section><img data-galleryid data-ratio=0.9131455399061033 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmuMVaz7tgzzibL9oMpmkEyFkPI8diaAChBp7RRzC2VJBDdaPF7lp7Lhw1g/640?wx_fmt=png" data-type=png data-w=426 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmuMVaz7tgzzibL9oMpmkEyFkPI8diaAChBp7RRzC2VJBDdaPF7lp7Lhw1g/640?wx_fmt=png"></section><section><br></section><section><strong><span><span>2、</span><span>黑素皮质素 4 受体（MC4R）拮抗剂</span></span></strong></section><section><span><br></span></section><section><span>辉瑞申请的 WO2023275715 所公开的以化合物 1.1.2 为代表的 3',4'-二氢-1'H-螺 [吡咯啉-3,2'-[1,8] 萘啶] 类化合物对 MC4R 的 Ki 最低可达 0.18nM。</span></section><section><br></section><section><span>化合物 1.1.2</span></section><section><img data-galleryid data-ratio=0.5613305613305614 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmuiaEG4LmDamN4sibf6BvdBGEhRuzH7sBk8zexo2zVZKZVtU8IBcPfPUjw/640?wx_fmt=png" data-type=png data-w=481 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmuiaEG4LmDamN4sibf6BvdBGEhRuzH7sBk8zexo2zVZKZVtU8IBcPfPUjw/640?wx_fmt=png"></section><section><br></section><section><span><strong><span>3、HPK1 抑制剂</span></strong></span></section><section><span><strong><span><br></span></strong></span></section><section><span>阿斯利康公司申请的 WO2023001794A1 所公开的以化合物 1.1.3 为代表的 3-氨基吡嗪羧酰胺化合物对 HPK1 的 IC50 最低可 &lt;3nM。除了前述的母核，各示例化合物均在吡嗪环的 6 位带有咪唑稠合六元芳香环基取代。</span></section><section><span><br></span></section><section><span>化合物 1.1.3</span></section><section><img data-galleryid data-ratio=0.7075718015665796 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmuQV51IR44HhxdhVGUI24ibtIXM4sN1eXQQLw3HWIcHnBmibjQlhiayYDXw/640?wx_fmt=png" data-type=png data-w=383 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmuQV51IR44HhxdhVGUI24ibtIXM4sN1eXQQLw3HWIcHnBmibjQlhiayYDXw/640?wx_fmt=png"></section><section><span><br></span></section><section><span><strong><span>4、PTPN2 降解剂</span></strong></span></section><section><br></section><section><span>WO2023019166（申请人：艾伯维）公开的以化合物 1.1.4 为代表的 PTPN2 降解剂对 PTPN2 的 DC50 最低可达 &lt;50nM。</span></section><section><span><br></span></section><section><span>化合物 1.1.4</span></section><section><img data-backh=497 data-backw=578 data-galleryid data-ratio=0.8590504451038575 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmuyTxn5FmNgcYgMXGj2ZKWcgnrPsQIicDG11WyiarvpkiaRO7abnyMXQ1TQ/640?wx_fmt=png" data-type=png data-w=674 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmuyTxn5FmNgcYgMXGj2ZKWcgnrPsQIicDG11WyiarvpkiaRO7abnyMXQ1TQ/640?wx_fmt=png"></section><section><br></section><section><span><strong><span>5、TEAD 降解剂</span></strong></span></section><section><span><strong><span><br></span></strong></span></section><section><span>WO2023031801（申请人：诺华公司）公开的以化合物 1.1.5 为代表的 TEAD 降解剂对 TEAD1 的 DC50 最低可达 &lt;0.3nM。作为 YAP/YAZ-TEAD 蛋白-蛋白相互作用抑制剂的红色部分（可对照后文的化合物 1.2-2 与 1.2-3）还可以通过 * 标注的羧酰氨基或氧甲基与连接子相连。</span></section><section><span><br></span></section><section><span>化合物 1.1.5</span></section><section><img data-galleryid data-ratio=0.5170178282009724 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmu0CG4v2ia7AoMJGtR22t2f18avELBPerpwyAW45ib1DpGnmmyRKWrViaVw/640?wx_fmt=png" data-type=png data-w=617 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmu0CG4v2ia7AoMJGtR22t2f18avELBPerpwyAW45ib1DpGnmmyRKWrViaVw/640?wx_fmt=png"></section><section><br></section><section><span><strong><span>6、PRMT5 抑制剂</span></strong></span></section><section><span><br></span></section><section><span>WO2023036974（申请人：阿斯利康）公开的一系列以化合物 1.1.6 为代表的 PRMT5 抑制剂对 PRMT5（+MTA）的 IC50 值可低达 nM 水平。</span></section><section><span><br></span></section><section><span>化合物 1.1.6</span></section><section><img data-galleryid data-ratio=0.9572446555819477 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmutT6WzSOOoembsl1ocxhJXdEXy3AZ4SzO0zoNPOcCftJwFl7JibGOlkg/640?wx_fmt=png" data-type=png data-w=421 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmutT6WzSOOoembsl1ocxhJXdEXy3AZ4SzO0zoNPOcCftJwFl7JibGOlkg/640?wx_fmt=png"></section><section><br></section><section><span><strong><span>7、WRN 抑制剂</span></strong></span></section><section><br></section><section><span>GSK 与 Ideaya Biosciences Inc 联合申请的 WO2023062575 公开了以化合物 1.1.7 为代表的 WRN 抑制剂，其对 WRN 的 IC50 最低可 ≤ 100nM。</span></section><section><span><br></span></section><section><span>化合物 1.1.7</span></section><section><img data-galleryid data-ratio=0.4773060029282577 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmu0LzOAbGN5QcvhN7pS7Gfocu2EBFKuSojic8Sn82ee2Bxib3spxxWDMgg/640?wx_fmt=png" data-type=png data-w=683 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmu0LzOAbGN5QcvhN7pS7Gfocu2EBFKuSojic8Sn82ee2Bxib3spxxWDMgg/640?wx_fmt=png"></section><section><br></section><section><span><strong><span>8、DNA 聚合酶 θ 抑制剂</span></strong></span></section><section><br></section><section><span>GSK 与 Ideaya Biosciences Inc 联合申请的 WO2023067515A1 公开的以化合物 1.1.8 为代表的噻二唑类化合物对 DNA 聚合酶 θ 的 IC50 最低可 ≤ 200nM。</span></section><section><span><br></span></section><section><span>化合物 1.1.8</span></section><section><img data-galleryid data-ratio=0.9032967032967033 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmuWHckQe1Th9kh6cxB1aV0kXvz550zBjf77uGQPFfiajW5SoILCKJj4ZA/640?wx_fmt=png" data-type=png data-w=455 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmuWHckQe1Th9kh6cxB1aV0kXvz550zBjf77uGQPFfiajW5SoILCKJj4ZA/640?wx_fmt=png"></section><section><br></section><section><br></section><section><span><span><strong><span> </span></strong></span><span><strong><span>  外周专利</span></strong></span></span></section><section><span><strong><span><br></span></strong></span></section><section><img data-galleryid data-ratio=3.1657894736842107 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmuMYoovDcNEJxqKM8ibKI8LTQ5l6IcvNgJYgqvwGuIYZcUiaIoevrVrwaQ/640?wx_fmt=png" data-type=png data-w=760 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmuMYoovDcNEJxqKM8ibKI8LTQ5l6IcvNgJYgqvwGuIYZcUiaIoevrVrwaQ/640?wx_fmt=png"></section><section><br></section><section><br></section><p><img data-backh=53 data-backw=578 data-galleryid data-ratio=0.09166666666666666 data-s=300,640 data-src="https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZZELxGdzcvb5smTN1Jpa5oSmkuYSKhxoZteNgXZAE0DDTL8Z3ibib4fSdyDObP4fGvLA9kFx8xacllw/640?wx_fmt=png" data-type=png data-w=1080 src="https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZZELxGdzcvb5smTN1Jpa5oSmkuYSKhxoZteNgXZAE0DDTL8Z3ibib4fSdyDObP4fGvLA9kFx8xacllw/640?wx_fmt=png"></p><section><span><strong><span>生物大分子</span></strong></span></section><section><span><strong><span><br></span></strong></span></section><section><span><span><strong><span> </span></strong></span><span><strong><span>  基础专利</span></strong></span></span></section><section><span><br></span></section><section><img data-backh=241 data-backw=578 data-galleryid data-ratio=0.416 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmutqMtqQgFJSiaGJzpQSMQLcYjYBRoCMd5sooDApL09xx9fXCmBCuRB2A/640?wx_fmt=png" data-type=png data-w=625 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmutqMtqQgFJSiaGJzpQSMQLcYjYBRoCMd5sooDApL09xx9fXCmBCuRB2A/640?wx_fmt=png"></section><section><br></section><section><span><span><strong><span> </span></strong></span><span><strong><span>  外周专利</span></strong></span></span></section><section><span><strong><span><br></span></strong></span></section><section><img data-backh=431 data-backw=578 data-galleryid data-ratio=0.7449306296691569 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmudibKwDN3bGxvettBtTyPapPGEqTplxKXaIaXpFqNj8UibSmBiaLgbv65A/640?wx_fmt=png" data-type=png data-w=937 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmudibKwDN3bGxvettBtTyPapPGEqTplxKXaIaXpFqNj8UibSmBiaLgbv65A/640?wx_fmt=png"></section><section><br></section><section><br></section><section><br></section><p><img data-backh=53 data-backw=578 data-galleryid data-ratio=0.09166666666666666 data-s=300,640 data-src="https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZZELxGdzcvb5smTN1Jpa5oSgmzgu7wuUwYWH5bAUemnew7uoSV2mZ3rGslAnnpoyBGZySianhBRh6A/640?wx_fmt=png" data-type=png data-w=1080 src="https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZZELxGdzcvb5smTN1Jpa5oSgmzgu7wuUwYWH5bAUemnew7uoSV2mZ3rGslAnnpoyBGZySianhBRh6A/640?wx_fmt=png"></p><section><span><strong><span>小  结</span></strong></span><br></section><section><span><br></span></section><section><span>本文提及的 MNC 及罗氏在 2023 年上半年公开的肿瘤相关 PCT 专利涉及的靶点如下表所示（排号内数值代表涉及的该公司申请的 PCT 专利数量）。</span></section><section><span><br></span></section><section><img data-backh=357 data-backw=578 data-galleryid data-ratio=0.6173421300659755 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmu0gbLcbWU8xzK0wEXLdD5TVVkVF4CV23DFceJREficic6hlQ9TBRm9zRw/640?wx_fmt=png" data-type=png data-w=1061 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZYAAuZL9vJpdYgsr9BVjxmu0gbLcbWU8xzK0wEXLdD5TVVkVF4CV23DFceJREficic6hlQ9TBRm9zRw/640?wx_fmt=png"></section><section><br></section><section><span>2023 上半年公开的上表中各 MNC 申请的肿瘤相关 PCT 专利涉及的靶点重叠率相对较低，其中<strong>涉及两家 MNC 申请的 PCT 专利中靶点则以加粗与下划线标示</strong>，提示各 MNC 肿瘤领域新药研发的差异化策略。</span></section><section><span><br></span></section><section><span>往期文章回顾 >> </span><span><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA4MzkzMDYyNw==&amp;mid=2649893931&amp;idx=1&amp;sn=d688c270e9396d8438047daffdcfb20b&amp;chksm=87e87747b09ffe5177fcd148b9902e3eec9e667721b54b35893dbf4a060b4564e35686cb9e3a&amp;scene=21#wechat_redirect" textvalue="透视罗氏制药 2023 上半年公开的肿瘤领域专利" linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2>透视罗氏制药 2023 上半年公开的肿瘤领域专利</a></span><span><br></span></section><section><span></span></section><section><br></section><section data-mpa-template=t mpa-from-tpl=t><section data-mpa-template=t mpa-from-tpl=t><section mpa-from-tpl=t><section mpa-from-tpl=t><section mpa-from-tpl=t><section><section><span><strong>封面来源：</strong></span><span>站酷海洛 Plus</span></section><section><span><strong>免责声明：</strong><span>本文仅作信息分享，不代表 Insight 立场和观点，也不作治疗方案推荐和介绍。如有需求，请咨询和联系正规医疗机构。</span></span></section><section><br></section><section><span><strong>编辑</strong>：Hebe</span></section><section><span><strong><span>PR 稿对接</span></strong><span>：微信 insightxb</span></span></section><section><span><strong><span>投稿</span></strong><span>：微信 insightxb；邮箱 insight@dxy.cn</span></span></section><section><span><br></span></section><hr><section><br></section><section><span>点击卡片进入 </span><span><strong>Insight 小程序</strong></span></section><section><span>国内审评进度、全球新药开发…</span></section><section><span>随时随地查！</span></section><section><mp-common-miniprogram data-miniprogram-nickname=Insight医药情报助手 data-miniprogram-avatar="http://mmbiz.qpic.cn/mmbiz_png/8T4HVUJDuYF2WXbXCEqZl90lJ8NIuiby0SqbBwkibzz6nglM7ia9fJMkn1G6Chz8bVK0yE3jicBBrLFgIOSibcsgk3w/640?wx_fmt=png&amp;amp;wxfrom=200" data-miniprogram-title=点击卡片，医药数据一键查询！ data-miniprogram-imageurl="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYRT3iaiao5IpcwWsK7fibuaxPgkckAWgsCTDgFiaYC40enddrMSOMbhrtGrbx0epaHIRan3MVfCHgI8g/0?wx_fmt=jpeg" data-miniprogram-type=card data-miniprogram-servicetype=0 data-pluginname=insertminiprogram data-miniprogram-appid=wx33d4c3735820a33e data-weui-theme=light data-miniprogram-path="pages/index/index?dxa_adplatform=7db80b691672736549"></mp-common-miniprogram></section><section><img data-backh=35 data-backw=542 data-before-oversubscription-url="https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZYnVllCouEEOdqo2iaqqnfQKB92kyKXnTAsX7DloH6icYmFC8LN4mwrwZXeQ5pqqwkDc38ib16FbGZpA/640?wx_fmt=png" data-copyright=0 data-ratio=0.06388888888888888 data-s=300,640 data-src="https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZYnVllCouEEOdqo2iaqqnfQKB92kyKXnTAsX7DloH6icYmFC8LN4mwrwZXeQ5pqqwkDc38ib16FbGZpA/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type=png data-w=1080 src="https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZYnVllCouEEOdqo2iaqqnfQKB92kyKXnTAsX7DloH6icYmFC8LN4mwrwZXeQ5pqqwkDc38ib16FbGZpA/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></section><section><span>多样化功能、可溯源数据……</span></section><section><span>Insight 数据库网页版等你体验<img data-ratio=1 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZapSKkMo4zKejyF1kwocYAdDgiaHuOPBnUFhqWicIL2pJVarklchCnjDxBbdCLIt3FXvuGicJOXnON7A/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type=png data-w=64 src="https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZapSKkMo4zKejyF1kwocYAdDgiaHuOPBnUFhqWicIL2pJVarklchCnjDxBbdCLIt3FXvuGicJOXnON7A/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></span><br></section><section><span>点击阅读原文，<strong>立刻</strong><strong>解锁</strong>！</span><img data-copyright=0 data-ratio=0.125 data-s=300,640 data-src="https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZZsSTG4CvxVOsgyYs36Biav0Peywg39IiboTfliboldm2SDTmYnbfopNhFNPQ8XXlfF9GeoNAGLRM3KQ/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type=png data-w=1080 src="https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZZsSTG4CvxVOsgyYs36Biav0Peywg39IiboTfliboldm2SDTmYnbfopNhFNPQ8XXlfF9GeoNAGLRM3KQ/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></section></section></section></section></section></section></section><section><section><br></section></section><section><section><br></section></section><p><mp-style-type data-value=3></mp-style-type></p></div><hr><a href=https://mp.weixin.qq.com/s/-eTloxwRtOurGeY4S-saVw ,target=_blank rel="noopener noreferrer">原文链接</a></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/fetched/ rel=tag>fetched</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/insight%E6%95%B0%E6%8D%AE%E5%BA%93/ rel=tag>Insight数据库</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/2023-08/%E4%B8%AD%E5%9B%BD%E6%9C%80%E5%A5%BD%E7%9A%84%E8%AE%B0%E5%BD%95%E7%89%87%E5%9C%A8%E6%8B%BC%E5%A4%9A%E5%A4%9A/ rel=prev><span class=pager__subtitle>«&#8201;Previous</span><p class=pager__title>中国最好的记录片在拼多多</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/2023-08/%E7%AC%AC%E5%85%AB%E5%B1%8A%E4%BE%A8%E7%95%8C%E8%B4%A1%E7%8C%AE%E5%A5%96%E4%BA%BA%E7%89%A9%E9%A3%8E%E9%87%87%E5%BD%95___%E8%91%A3%E5%AD%90%E9%92%A2_%E4%BB%81%E5%BF%83%E4%BB%81%E6%9C%AF_%E6%B5%8E%E4%B8%96%E8%89%AF%E5%8C%BB/ rel=next><span class=pager__subtitle>Next&#8201;»</span><p class=pager__title>第八届侨界贡献奖人物风采录—— 董子钢：仁心仁术，济世良医</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Search… name=q aria-label=Search…>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/2025-02/%E7%99%BE%E4%B8%87%E9%AA%91%E6%89%8B%E4%B8%8A%E7%A4%BE%E4%BF%9D_%E7%A1%AE%E5%AE%9A%E8%BF%99%E6%98%AF%E4%BB%B6%E5%A5%BD%E4%BA%8B_/>百万骑手上社保，确定这是件好事？</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-02/%E4%B8%80%E7%A7%92%E8%B6%85%E7%A5%9E_deepseek___%E8%BF%99%E4%B8%A4%E4%B8%AA%E5%85%8D%E8%B4%B9%E5%B7%A5%E5%85%B7_%E6%8F%90%E5%89%8D%E6%84%9F%E5%8F%97_agi_%E9%80%BC%E8%BF%91/>一秒超神：Deepseek + 这两个免费工具！提前感受 AGI 逼近</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-02/%E4%B8%8D%E8%A7%84%E5%88%92%E4%B9%9F%E6%B2%A1%E5%85%B3%E7%B3%BB/>不规划也没关系</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-02/%E8%B4%A2%E6%96%B0%E5%91%A8%E5%88%8A_%E6%B4%97%E9%92%B1%E6%B5%81%E6%B0%B4%E8%B6%85170%E4%BA%BF%E5%85%83_%E8%99%9A%E6%8B%9F%E5%B8%81%E5%9C%B0%E4%B8%8B%E9%92%B1%E5%BA%84%E6%8C%91%E6%88%98%E7%9B%91%E7%AE%A1%E4%B8%8E%E6%89%A7%E6%B3%95/>财新周刊｜洗钱流水超170亿元 虚拟币地下钱庄挑战监管与执法</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-02/%E8%BF%99%E5%B9%B4%E5%A4%B4_%E7%BB%99%E4%BA%A4%E4%BA%94%E9%99%A9%E4%B8%80%E9%87%91%E9%83%BD%E6%88%90%E6%96%B0%E9%97%BB%E4%BA%86/>这年头，给交五险一金都成新闻了</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/duty/>Duty</a></li><li class=widget__item><a class=widget__link href=../../../categories/duty2/>Duty2</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/cnbeta/ title=Cnbeta>Cnbeta (91)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/fetched/ title=Fetched>Fetched (615)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/githubdaily/ title=GitHubDaily>GitHubDaily (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E4%B8%81%E9%A6%99%E5%9B%AD/ title=丁香园>丁香园 (28)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E4%BA%BA%E7%89%A9/ title=人物>人物 (14)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%8D%97%E6%96%B9%E5%91%A8%E6%9C%AB/ title=南方周末>南方周末 (11)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%B0%8F%E4%BC%97%E8%BD%AF%E4%BB%B6/ title=小众软件>小众软件 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%B0%8F%E5%A4%A7%E5%A4%AB%E6%BC%AB%E7%94%BB/ title=小大夫漫画>小大夫漫画 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%B0%91%E6%95%B0%E6%B4%BE/ title=少数派>少数派 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%BE%AA%E5%9B%A0%E7%BC%89%E8%8D%AF/ title=循因缉药>循因缉药 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%98%9F%E7%90%83%E5%95%86%E4%B8%9A%E8%AF%84%E8%AE%BA/ title=星球商业评论>星球商业评论 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%A7%BD%E8%BE%B9%E5%BE%80%E4%BA%8B/ title=槽边往事>槽边往事 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%AF%8F%E6%97%A5%E4%BA%BA%E7%89%A9/ title=每日人物>每日人物 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%B5%AE%E4%B9%8B%E9%9D%99/ title=浮之静>浮之静 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%81%BC%E8%A7%81/ title=灼见>灼见 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%94%9F%E4%BF%A1%E6%8A%80%E8%83%BD%E6%A0%91/ title=生信技能树>生信技能树 (9)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90/ title=知识分子>知识分子 (13)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%BD%91%E6%98%93%E6%95%B0%E8%AF%BB/ title=网易数读>网易数读 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E8%B4%A2%E7%BB%8F%E4%B8%89%E5%88%86%E9%92%9F/ title=财经三分钟>财经三分钟 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E8%B5%9B%E5%85%88%E7%94%9F/ title=赛先生>赛先生 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E9%83%91%E5%B7%9E%E6%A5%BC%E5%B8%82/ title=郑州楼市>郑州楼市 (32)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2025 文字轨迹.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>